Related Experiment Video
Updated: Nov 16, 2025
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.1K
Extracellular Vesicles From Perinatal Cells for Anti-inflammatory Therapy
Anna Cargnoni1, Andrea Papait1,2, Alice Masserdotti2
1Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Frontiers in Bioengineering and Biotechnology
|February 22, 2021
Summary
Perinatal cells and their extracellular vesicles (EVs) modulate immune responses, offering promising therapeutic potential for regenerative medicine and treating inflammatory diseases.
Area of Science:
- Immunology
- Regenerative Medicine
- Cell Biology
Background:
- Perinatal cells possess unique immunological properties beneficial for fetal development.
- These cells modulate innate and adaptive immune cells, showing promise for regenerative medicine.
- Extracellular vesicles (EVs) are emerging as cell-free therapeutics for modulating inflammation.
Purpose of the Study:
- To review the immunomodulatory potential of perinatal cells and their derived EVs.
- To explore the role of EVs in modulating the inflammatory microenvironment for tissue regeneration.
- To discuss the therapeutic applications of perinatal EVs in inflammatory pathologies.
Main Methods:
- Literature review of studies on perinatal cell immunology and EVs.
- Analysis of mechanisms by which perinatal EVs modulate immune cells.
- Examination of EV cargo (growth factors, miRNA) and their bioactive functions.
Main Results:
- Perinatal cells and their EVs exhibit significant immunomodulatory effects.
- EVs mediate therapeutic actions by delivering bioactive molecules and modulating inflammation.
- Perinatal EVs show potential in treating acute and chronic inflammatory conditions.
Conclusions:
- Perinatal-derived EVs are potent therapeutic agents for immune modulation and tissue repair.
- Their cell-free nature and therapeutic cargo make them valuable in regenerative medicine.
- Further research into perinatal EVs can unlock new treatments for inflammatory diseases.
Related Concept Videos
01:36Overview of Exosomes
3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
01:15Transcytosis of IgG
3.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.7K